Multiple sclerosis symptom management
- PMID: 17868019
- DOI: 10.1586/14737175.7.9.1213
Multiple sclerosis symptom management
Abstract
Multiple sclerosis (MS) is the most common cause of nontraumatic disability in young adults. The increasing emphasis on early treatment with disease-modifying therapies has the goal of preventing long-term disability. However, current disease treatments are only partially effective, and most patients experience a variety of neurologic symptoms at various times during their disease course. Because these symptoms often have a profound impact on social, occupational and physical performance, effective symptom management is an important component of therapy to maintain quality of life. Effective symptom management often requires a multidisciplinary team approach. This review outlines general principles of the management of MS symptoms.
Similar articles
-
Symptomatic management in multiple sclerosis.Neurol Clin. 2011 May;29(2):449-63. doi: 10.1016/j.ncl.2011.01.008. Neurol Clin. 2011. PMID: 21439453 Review.
-
Managing the symptoms of multiple sclerosis: a multimodal approach.Clin Ther. 2006 Apr;28(4):445-60. doi: 10.1016/j.clinthera.2006.04.005. Clin Ther. 2006. PMID: 16750459 Review.
-
Symptom management.Adv Neurol. 2006;98:227-55. Adv Neurol. 2006. PMID: 16400837 Review. No abstract available.
-
[Symptomatic therapies for multiple sclerosis].Nihon Rinsho. 2003 Aug;61(8):1355-60. Nihon Rinsho. 2003. PMID: 12962023 Review. Japanese.
-
The place of the botulinum toxin in the management of multiple sclerosis.Clin Neurol Neurosurg. 2010 Sep;112(7):592-6. doi: 10.1016/j.clineuro.2010.04.010. Epub 2010 Jul 8. Clin Neurol Neurosurg. 2010. PMID: 20615606 Review.
Cited by
-
Contraceptive use among women with multiple sclerosis: a systematic review.Contraception. 2016 Dec;94(6):612-620. doi: 10.1016/j.contraception.2016.07.013. Epub 2016 Jul 21. Contraception. 2016. PMID: 27452316 Free PMC article.
-
The multiple sclerosis self-management scale: clinicometric testing.Int J MS Care. 2014 Summer;16(2):61-7. doi: 10.7224/1537-2073.2013-019. Int J MS Care. 2014. PMID: 25061429 Free PMC article.
-
Astroglial and Microglial Purinergic P2X7 Receptor as a Major Contributor to Neuroinflammation during the Course of Multiple Sclerosis.Int J Mol Sci. 2021 Aug 5;22(16):8404. doi: 10.3390/ijms22168404. Int J Mol Sci. 2021. PMID: 34445109 Free PMC article. Review.
-
Potential Utility of Natural Products against Oxidative Stress in Animal Models of Multiple Sclerosis.Antioxidants (Basel). 2022 Jul 29;11(8):1495. doi: 10.3390/antiox11081495. Antioxidants (Basel). 2022. PMID: 36009214 Free PMC article. Review.
-
Promising Nanotechnology Approaches in Treatment of Autoimmune Diseases of Central Nervous System.Brain Sci. 2020 Jun 2;10(6):338. doi: 10.3390/brainsci10060338. Brain Sci. 2020. PMID: 32498357 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical